In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
US biotech firm Alexion Pharmaceuticals has appointed Ludwig Hantson as chief executive and member of the board of directors, effective immediately. 27 March 2017
Pharmaceutical
Claude Bertrand started on Monday in his new role as general director of research and development (R&D) and chief scientific officer (CSO) at privately-held French drugmaker Servier. 27 March 2017
Biotechnology
US-based Boston Biomedical is making new senior appointments in oncology, as the company’s founder Chiang J. Li steps down from his role as chief executive. 23 March 2017
Pharmaceutical
The US subsidiary of Japanese pharma major Eisai has appointed Kirk Shepard as senior vice president, global medical affairs of the Oncology Business Group. 17 March 2017
Biotechnology
Biogen has appointed Anirvan Ghosh as senior vice president, research and early development (RED). 16 March 2017
Pharmaceutical
US pharma major Bristol-Myers Squibb has appointed Dr Thomas Lynch, Jr, as executive vice president and chief scientific officer, effective March 16, 2017. 9 March 2017
Biotechnology
USA/Israel-based biotech firm BrainStorm Cell Therapeutics has appointed Ralph Kern to the positions of chief operating and chief medical officer, effective March 6, 2017. 6 March 2017
Pharmaceutical
Denmark-based allergy specialist ALK-Abelló has appointed Hendrik Nolte as senior vice president of R&D for North America and International Markets, based in the USA. 3 March 2017
Pharmaceutical
French drugmaker Ipsen has appointed Benoit Hennion as executive vice president and president of primary care. 2 March 2017
Pharmaceutical
Investors in Ireland-incorporated Perrigo probably did not know where to turn on Monday and Tuesday amid news on the company’s management, job cuts, divestment of royalty payment rights on a multiple sclerosis drug and its publication of bleak financial guidance. 1 March 2017
Pharmaceutical
Jakob Riis, executive vice president, head of North America Operations and president of Novo Nordisk Inc, has resigned, Danish diabetes care giant Novo Nordisk announced this morning. 1 March 2017
Biotechnology
US biotech major Celgene Corp says that its president and chief operating officer (COO) Jacqualyn (Jackie) Fouse, has decided to retire from Celgene effective June 30, 2017. 24 February 2017
Biotechnology
US biotech PureTech Health has named Atul Pande its chief medical officer. 24 February 2017
Pharmaceutical
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Nathalie Moll as its new director general. 22 February 2017
Pharmaceutical
US pharma major Bristol-Myers Squibb has announced the appointment to the board of three new independent directors. 22 February 2017
Pharmaceutical
Teijin Pharma, the core company of Japan’s Teijin Group’s healthcare business, says that its board of directors has elected Akihisa Nabeshima as its next president. 22 February 2017
Pharmaceutical
A pharma veteran has switched from one of the industry’s giants to another to lead its UK pharmaceuticals business. 15 February 2017
Pharmaceutical
While last week’s news continued to be dominated by actions of newly-installed US President Donald Trump, including the vote to approve his controversial nominee Dr Tom Price as Secretary of Health and Human Services, the pharma industry itself was also making headlines. 12 February 2017
Pharmaceutical
Christine Lind has been appointed as the new chief executive of Swedish drugmaker Medivir. 9 February 2017
Biotechnology
Oxford BioTherapeutics (OBT) has added two new names to a board now boasting significant experience in developing immuno-oncology and antibody-based therapies. 9 February 2017
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze